Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Cat Allergy
NCT01003301Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2009
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of omalizumab in cat allergy, sponsored by Johns Hopkins University. Started Oct 2009; status: completed.
02
Drugs
omalizumab
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT01003301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003301.